Fundraising FoxSymBiosis — Full Portfolio
11 tracked investments · listed companies and verified rows first
Clene is a clinical-stage biopharmaceutical company developing nanotherapeutics that target cellular energy impairments to treat neurodegenerative diseases and restore neuronal health.
BiotechDeep TechHealthtechSalt Lake City, US
Mark Mortenson(Executive Officer)inReed N. Wilcox(Independent Director)Morgan Brown(Executive Officer)inRobert Glanzman(Executive Officer)inTae Heum Jeong(Executive Officer)Robert Etherington(President, Chief Executive Officer, and Director)
Board seatChidozie Ugwumba· per SEC Form D · $9.3M raise · filed May 2021
CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
BiotechPhiladelphia, US
Steven Kelly(Executive Officer, Director)in
BoardMargarita Chavez(Director)inEran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)Regina Hodits(Director)in
Board seatChidozie Ugwumba· per SEC Form D · $70.4M raise · filed Jan 2021
Co-investorsAgent CapitalAju IB Invesment CorporationAnzu PartnersGrazia Equity GmbHHealthCapMRL Ventures Fund+3 more
Apollo is a venture capital firm that invests in life-science and biotechnology startups, combining entrepreneurial expertise with deep scientific knowledge to support early-stage companies in drug development and personalized medicine.
BiotechDeep TechHealthtechLongevity
Nils Regge(Co-Founder & General Partner)in
Co-investorsBLN CapitalCoastCapFJ LabsKfW CapitalTruVenturo GmbHCTI Life Sciences Fund L.P.+3 more
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
BoardGeorge M. Church(Director)
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPHBM Healthcare InvestmentsHBM PartnersKhosla Ventures+13 more
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Albert Seymour(Director)
BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in
Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalSolasta Ventures+8 more
Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program.
BiotechHealthtechMedical DevicesPhiladelphia, US
Co-investorsHBM Healthcare InvestmentsHBM PartnersLG Technology VenturesNovartis Venture FundOrbiMedPontifax Venture Capital+3 more
Kernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Yusuf Erkul(Founder)inJeff Ozdemir(Founder)inBurak Yilmaz(Founder)inBurak YILMAZ(Founder)inCatherine Moroski(Executive Officer, Director)inOguzhan Yilmas(Director)
Co-investorsAsymmetry VenturesCivilization Ventures Management, LlcFoundersX VenturesHOF CapitalHummingbird VenturesSAV (Scale Asia Ventures)+13 more
Known Medicine develops a predictive engine using AI and patient datasets to identify optimal cancer treatments for individual patients.
AI & Machine LearningBiotechHealthtechMedical DevicesSalt Lake City, US
Andrea Mazzocchi(Co-founder, PhD)inKatie-Rose Skelly(Co-founder, MS)in
Co-investorsY CombinatorCota CapitalForward Venture CapitalCaffeinated CapitalFORWARD.oneKhosla Ventures+3 more
Neurona Therapeutics is a clinical-stage biotherapeutics company developing allogeneic neural cell therapies to treat chronic disorders of the nervous system.
BiotechDeep TechHealthtechSouth San Francisco, US
Cory Nicholas(Executive Officer, Director, Promoter)inJames Stutz(Chief Financial Officer and Chief Business Officer)inCatherine Priest(Chief Development Officer)inGautam Banik(Chief Technology Officer)inEduardo Dunayevich(Chief Medical Officer)inArnold Kriegstein(Director)
Co-investorsBerkeley FrontierIaso VenturesThe Column GroupYsios CapitalAlexandriaFidelity Investments+7 more
SonoThera is developing a nonviral, non-invasive gene delivery technology that uses ultrasound and microbubbles (ultrasound-mediated delivery) to deliver genetic payloads to targeted sites in a redosable way.
BiotechDeep TechDigital HealthHealthtechSouth San Francisco, US
Kenneth Greenberg(Co-Founder, President & CEO)in
Co-investorsVida VenturesLeaps by BayerARCH Venture PartnersFoothill VenturesIllumina VenturesMedical Excellence Capital+8 more
Tailor-ED develops personalized learning experiences using learning science principles.
AI & Machine LearningEdTechHR TechSaaSTel Aviv-Yafo, IL
Yael Cohen Haramaty(Founder)inMaayan Yavne(Founder)in
Co-investorsY CombinatorARC VENTURESBenson Oak Venturesfresh.fundLucas Venture Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.